Polyclone Lifesciences Private Limited - Company Profile

It is a trading private limited company based in Bangalore, Karnataka, India, established in 2013.
2013 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Polyclone Lifesciences Private Limited

Polyclone Lifesciences Private Limited, a struck off private limited company, was established on 21 February 2013 in Bangalore, Karnataka, India. Engaging in specialty within the trading sector, it holds CIN: U51909KA2013PTC067957. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.20 M.

Its leadership includes Naveen Kulkarni (Director), Rajendra Praveen (Director), Sanjay Bettadpura Shripathy (Director). It is based at # 437, Ground Floor, 40Th Cross 5Th Block, Jayanagar, Bangalore, Karnataka, 560041.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909KA2013PTC067957

  • Registration Number

    067957

  • Incorporation Date

    21 February 2013

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.20 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.20 M
  • Company Age 13 Year, 19 Days
Company report

Polyclone Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Polyclone Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Polyclone Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Naveen Kulkarni Director 21 Feb 2013 Current
Rajendra Praveen Director 21 Feb 2013 Current
Sanjay Bettadpura Shripathy Director 21 Feb 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Polyclone Lifesciences.

Enhance accessibility to Polyclone Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Polyclone Lifesciences revenue growth over time
Polyclone Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Polyclone Lifesciences?

Unlock access to Polyclone Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Polyclone Lifesciences?

Unlock and access historical data on people associated with Polyclone Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Polyclone Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polyclone Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Polyclone Lifesciences
Recent Activity within the Organization
  • Director Appointment

    Progress on Naveen Kulkarni was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 13 years 19 days . was documented.

  • Director Appointment

    The activity Rajendra Praveen was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 13 years 19 days . was completed.

  • Director Appointment

    The activity Sanjay Bettadpura Shripathy was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 13 years 19 days . was completed.

  • Company Incorporation

    Progress on Polyclone Lifesciences Private Limited was registered on 21 Feb 2013 with Roc Bangalore & aged 13 years 19 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Polyclone Lifesciences Private Limited?

The CIN of Polyclone Lifesciences Private Limited is U51909KA2013PTC067957.

Where is Polyclone Lifesciences Private Limited headquartered?

Polyclone Lifesciences Private Limited is headquartered at # 437, Ground Floor, 40Th Cross 5Th Block, Jayanagar, Bangalore, Karnataka, 560041.

When was Polyclone Lifesciences Private Limited incorporated?

Polyclone Lifesciences Private Limited was incorporated on 21 February 2013.

Who are the current directors of Polyclone Lifesciences Private Limited?

The current directors of Polyclone Lifesciences Private Limited are

What is the primary industry of Polyclone Lifesciences Private Limited?

The primary industry of Polyclone Lifesciences Private Limited is Trading.

Is Polyclone Lifesciences Private Limited a listed company?

Polyclone Lifesciences Private Limited is unlisted.

What is the capital structure of Polyclone Lifesciences Private Limited?

The authorized capital of Polyclone Lifesciences Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available